RecruitingPhase 3NCT06290869
Official study title

Tobacco Education and Lung Health Study (TEAL)

Study summary

Primary Objective To compare two smoking cessation interventions among individuals undergoing lung cancer screening. Primary outcomes are: 3-month self-reported abstinence from cigarettes and 6-month self-reported and bioverified abstinence from cigarettes. Secondary Objectives 1) To evaluate reach and engagement overall and by subgroup (e.g., race and ethnicity, underinsured, readiness to quit). 2) To conduct an economic analysis to evaluate intervention costs from the health system perspective.

Ask AI to explain this study
Start here

Key things to know

Main goalTreatment

This describes the study’s primary purpose.

What is being studiedPhone-based Tobacco Treatment, Nicotine Replacement, and Stepped Care Intervention and E-Referral to the Tobacco Quitline

The study team can explain what participation involves.

Who it may be forSmoking Cessation

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Feb 17, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Phase 3

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Georgetown University

Study sponsor

01
Study overview

What this study is about

Purpose
Treatment
Study type
Interventional
Phase
Phase 3
Sponsor
Georgetown University
Interventions being studied
Behavioral: Phone-based Tobacco Treatment, Nicotine Replacement, and Stepped Care Intervention; Behavioral: E-Referral to the Tobacco Quitline
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • eligible for a screening or diagnostic scan,
  • USPSTF eligibility criteria (50-80 years old and \>20-pack years);
  • currently smoking cigarettes (\>1 in the past 30 days);
  • English speaking;
  • able to provide meaningful consent.
Reasons someone may not be able to joinExclusion criteria
  • prior lung cancer,
  • hearing impairment,
  • cognitive impairment,
  • household member already enrolled.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Georgetown University Medical CenterWashington D.C., District of Columbia

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 17, 2026. Always confirm current availability with the study team.

View original record ↗